Table of Contents

December 01, 2014; Volume 11,Issue 4

  1. Amaria, Rodabe N.

    1. Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
      Kim Teresa, Rodabe N. Amaria, Christine Spencer, Alexandre Reuben, Zachary A. Cooper and Jennifer A. Wargo
      Cancer Biology & Medicine December 2014, 11 (4) 237-246; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.002

  2. Avdalyan, Ashot Merudzhanovich

    1. Argyrophilic nucleolar organizer region in MIB-1 positive cells in non-small cell lung cancer: clinicopathological significance and survival
      Dmitriy Sergeevich Kobyakov, Ashot Merudzhanovich Avdalyan, Aleksandr Fedorovich Lazarev, Elena Leonidovna Lushnikova and Lev Moiseevich Nepomnyashchikh
      Cancer Biology & Medicine December 2014, 11 (4) 264-269; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.005

  3. Bashir, Fahim

    1. Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports
      Mohan Hingorani, Sanjay Dixit, Fahim Bashir, Mohammad Butt, Simon Hawkyard, Richard Khafagy and Andrew Robertson
      Cancer Biology & Medicine December 2014, 11 (4) 277-280; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04-007

  4. Bi, Jun-Feng

    1. Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance
      Si-Han Wu, Jun-Feng Bi, Timothy Cloughesy, Webster K. Cavenee and Paul S. Mischel
      Cancer Biology & Medicine December 2014, 11 (4) 255-263; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.004

  5. Butt, Mohammad

    1. Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports
      Mohan Hingorani, Sanjay Dixit, Fahim Bashir, Mohammad Butt, Simon Hawkyard, Richard Khafagy and Andrew Robertson
      Cancer Biology & Medicine December 2014, 11 (4) 277-280; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04-007

  6. Cavenee, Webster K.

    1. Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance
      Si-Han Wu, Jun-Feng Bi, Timothy Cloughesy, Webster K. Cavenee and Paul S. Mischel
      Cancer Biology & Medicine December 2014, 11 (4) 255-263; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.004

  7. Chen, Jia

    1. Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
      Guo-Hao Xia, Yun Zeng, Ying Fang, Shao-Rong Yu, Li Wang, Mei-Qi Shi, Wei-Li Sun, Xin-En Huang, Jia Chen and Ji-Feng Feng
      Cancer Biology & Medicine December 2014, 11 (4) 270-276; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.006

  8. Cloughesy, Timothy

    1. Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance
      Si-Han Wu, Jun-Feng Bi, Timothy Cloughesy, Webster K. Cavenee and Paul S. Mischel
      Cancer Biology & Medicine December 2014, 11 (4) 255-263; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.004

  9. Cooper, Zachary A.

    1. Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
      Kim Teresa, Rodabe N. Amaria, Christine Spencer, Alexandre Reuben, Zachary A. Cooper and Jennifer A. Wargo
      Cancer Biology & Medicine December 2014, 11 (4) 237-246; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.002

  10. Dixit, Sanjay

    1. Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports
      Mohan Hingorani, Sanjay Dixit, Fahim Bashir, Mohammad Butt, Simon Hawkyard, Richard Khafagy and Andrew Robertson
      Cancer Biology & Medicine December 2014, 11 (4) 277-280; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04-007
« Previous (Pages : 1 2 3 4 5 ... 5) Next »
Back to top

In this issue

Cancer Biology and Medicine: 11 (4)
Cancer Biology & Medicine
Vol. 11, Issue 4
1 Dec 2014

Submit

Sign up for alerts